Disclosures
* Weight loss not guaranteed. Individual results vary and not all patients will qualify for treatment. Images, photos, and statements are for illustrative purposes only and do not guarantee outcomes.
** All medications are prescription-only and provided only after evaluation by a licensed healthcare provider. Telehealth services are subject to provider approval and clinical eligibility. Clinically appropriate treatment may include GLP-1 medications (e.g., semaglutide or tirzepatide). Weight-loss counseling and other services are offered as clinically appropriate.
§ Prices apply only to patients approved by a licensed provider. Prepaid plan prices require payment of the full plan total. Offers may vary by state and eligibility.
† Medications and services may vary by state.
‡ MultiMedRx is not affiliated with the manufacturers of Ozempic®, Wegovy®, Zepbound®, or any other referenced medications. See a licensed provider for complete safety information.
¶ Compounded medications are prepared by a licensed pharmacy for an individual patient. They are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality.
Important Safety Information
- Common side effects of GLP-1 medications include nausea, vomiting, diarrhea, constipation, and abdominal pain. Serious risks include pancreatitis, gallbladder disease, low blood sugar, kidney problems, and thyroid C-cell tumors.
- Tirzepatide has a Boxed Warning for thyroid C-cell tumors. Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2. Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain. Serious risks include pancreatitis, gallbladder disease, low blood sugar, kidney problems, and GI complications.